62 results
Page 2 of 4
8-K
EX-99.1
svhu96yqr
11 Aug 23
Other Events
6:34am
424B3
7nsq5e4u9z6xo5
30 Jun 23
Prospectus supplement
4:05pm
S-4/A
qs0u 3an05m5dingjk
29 Jun 23
Registration of securities issued in business combination transactions (amended)
4:09pm
S-4
1p35 1apxe25
8 Jun 23
Registration of securities issued in business combination transactions
8:03am
425
EX-99.1
yybowdcn0zo 3n
24 May 23
Business combination disclosure
4:55pm
8-K
EX-99.1
kxk3a
24 May 23
Regulation FD Disclosure
4:53pm
425
zt7 s9hibxpdp
24 May 23
Business combination disclosure
7:05am
425
9g3u03rdk 71h
24 May 23
Business combination disclosure
7:03am
8-K
EX-2.1
cnub5ogf92ir97n
24 May 23
Pyxis Oncology to Acquire Apexigen
6:59am
8-K
EX-99.1
7j4pe j9piobtwi5t9v
11 May 23
Pyxis Oncology Reports Financial Results for the First Quarter 2023
7:16am
S-3
7obm6
1 Nov 22
Shelf registration
4:51pm
8-K
EX-99.1
wxow3qy u97
1 Nov 22
Expands worldwide licensing agreement with Pfizer to obtain additional antibody-drug conjugate (ADC) platform components
7:14am
8-K
EX-99.1
osce2j
15 Aug 22
Prioritized pipeline to focus on most advanced programs while maintaining financial flexibility to pursue business development opportunities
7:11am